Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice

Molecular Immunology

Volumn 48, Issue 9-10, 2011, Pages 1203-1208

  Xi, Wenjin ^a,f   Hu, Yejia ^a,b   Liu, Yugang ^a   Zhang, Jiao ^c   Wang, Lei ^d   Lou, Yunwei ^a   Qu, Zhonghua ^a   Cui, Jian ^a   Zhang, Guizhong ^a   Liang, Xiaohong ^a   Ma, Chunhong ^a   Gao, Chengjiang ^a   Chen, Youhai ^e   Liu, Suxia ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Binzhou Medical University   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^d THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Inflammation; Peripheral blood mononuclear cells; TNFAIP8L2 (TIPE2)

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; PROTEIN TIPE2; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS LOAD; WILD TYPE;

ADOLESCENT; ADULT; ANIMALS; CASE-CONTROL STUDIES; CHILD; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; LIVER; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; RNA, MESSENGER;

HEPATITIS B VIRUS; MURINAE; MUS;

EID: 79954576940     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.03.002     Document Type: Article

References (44)

1. Ando K., Guidotti L.G., Wirth S., Ishikawa T., Missale G., Moriyama T., Schreiber R.D., Schlicht H.J., Huang S.N., Chisari F.V. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 1994, 152:3245-3253.
2. Barnaba V., Franco A., Paroli M., Benvenuto K., De Petrillo G., Burgio V.L., Santilio L., Balsano C., Cappelli G. Selective expansion of cytotoxic T lymphocytes with a CD+4, CD+56 surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J. Immunol. 1994, 152:3074-3087.
3. Bertoletti A., Delios M.M., Boni C., Carolina B., Carli M.D., Zignego A.L., Durazzo M., Messale G., Penna A., Ferrai C. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infection. Gastroenterology 1997, 112:193-199.
4. Carmody R.J., Hilliard B., Maguschak K., Chodosh L.A., Chen Y.H. Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation. J. Neuroimmunol. 2002, 133:95-107.
5. Chisari F.V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 1995, 13:29-60.
6. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol. 2001, 22:633-640.
7. Desmet V.J., Gerber M., Hoofnagle J.H., Manns M., Scheuer P.J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994, 19:1513-1520.
8. Ferrari C., Penna A., Bertoletti A., Valli A., Antoni A.D., Giuberti T., Cavalli A., Petit M.A., Fiaccadori F. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 1990, 145:3442-3449.
9. Freundt E.C., Bidere N., Lenardo M.J. A different TIPE of immune homeostasis. Cell 2008, 133:401-402.
10. Fukuda R., Ishimura N., Ngugen T.X., Chowdhury A., Ishihara S., Kohge N. The expression of IL-2, IL-4 and interferon gama (IFN-γ) mRNA using liver biopsies at different stages of acute exacerbation of chronic hepatitis B. Clin. Exp. Immunol. 1995, 100:446-451.
11. Ganem D., Prince A.M. Hepatitis B virus infection-natural history and clinical consequences. N. Engl. J. Med. 2004, 350:1118-1129.
12. Guidotti L.G., Ishikawa T., Hobbs M.V., Matzke B., Schreiber R., Chisari F.V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996, 4:25-36.
13. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999, 284:825-829.
14. Jung M.C., Spengler U., Schraut W., Hoffmann R., Zachoval R., Eisenburg J., Eichenlaub D., Riethmüller G., Paumgartner G., Ziegler-Heitbrock H.W. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J. Hepatol. 1991, 13:310-317.
15. Kakimi K., Guidotti L.G., Koezuka Y., Chisari F.V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 2000, 192:921-930.
16. Kallei L., Hahn A., Roder V.Z. Correlation between histological findings and serum transaminase values in chronic chronic diseases of the liver. Acta Med. Scand. 1964, 175:49-56.
17. Karmen A., Wroblewski F., LaDue J.S. Transaminase activity in human blood. J. Clin. Invest. 1955, 34:126-133.
18. Knodell R.G., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N., Kiernan T.W. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981, 1:431-435.
19. Koziel M.J. Immunology of viral hepatitis. Am. J. Med. 1996, 100:98-109.
20. Kumar D., Whiteside T.L., Kasid U. Identification of a novel tumor necrosis factor-alpha-inducible gene SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin-1 beta-converting enzyme-inhibitory protein. J. Biol. Chem. 2000, 275:2973-2978.
21. Kumar D., Gokhale P., Broustas C., Chakravarty D., Ahmad I., Kasid U. Expression of SCC-S2, an antiapoptotic molecule, correlates with enhanced proliferation and tumorigenicity of MDA-MB 435 cells. Oncogene 2004, 23:612-616.
22. Lee J.Y., Chae D.W., Kim S.M., Nam E.S., Jang M.K., Lee J.H., Kim H.Y., Yoo J.Y. Expression of FasL and perforin/granzyme B mRNA in chronic hepatitis B virus infection. J. Viral Hepat. 2004, 11:130-135.
23. Li D., Song L., Fan Y., Li X., Li Y., Chen J., Zhu F., Guo C., Shi Y., Zhang L. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin. Immunol. 2009, 133:422-427.
24. Liu F., Song Y., Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999, 6:1258-1266.
25. Liu Y.G., Liu S.X., Liang X.H., Zhang Q., Gao L.F., Han L.H., Cao Y.L., Hou N., Du J., Sun W.S. Blockade of TRAIL pathway ameliorates HBV-induced hepatocyte apoptosis in an acute hepatitis model. BBRC 2007, 352:329-334.
26. Myers R.P., Tainturier M.H., Ratziu V., Piton A., Thibault V., Imbert-Bismut F., Messous D., Charlotte F., Di Martino V., Benhamou Y., Poynard T. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J. Hepatol. 2003, 39:222-230.
27. Patel S., Wang F.H., Whiteside T.L., Kasid U. Identification of seven differentially displayed transcripts in human primary and matched metastatic head and neck squamous cell carcinoma cell lines: implications in metastasis and/or radiation response. Oral Oncol. 1997, 33:197-203.
28. Penna A., Chisari F.V., Bertoletti A., Missale G., Fowler P., Giuberti T., Fiaccadori F., Ferrari C. Cytotoxic T lymphocytes recognize an HLAA2- restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 1991, 174:1565-1570.
29. Penna A., Del Prete G., Cavalli A., Bertoletti A., D'Elios M.M., Sorrentino R., D'Amato M., Boni C., Pilli M., Fiaccadori F. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 1997, 25:1022-1027.
30. Peters M., Vierling J., Gershwin M.E., Milich D., Chisari F.V., Hoofnagle J.H. Immunology and the liver. Hepatology 1991, 3:977-994.
31. Rehermann B., Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 2005, 5:215-229.
32. Rehermann B., Fowler P., Sidney J., Person J., Redeker A., Brown M., Moss B., Sette A., Chisari F.V. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 1995, 181:1047-1058.
33. Rosser B.G., Gores G. Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology 1995, 108:252-275.
34. 8+ T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J. Immunol. 2010, 184:287-295.
35. Sun H., Gong S., Carmody R.J., Hilliard A., Li L., Sun J., Kong L., Xu L., Hilliard B., Hu S., Shen H., Yang X., Chen Y.H. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 2008, 133:415-426.
36. Trobonjaca Z., Leithauser F., Moller P., Schirmbeck R., Reimann J. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. J. Immunol. 2001, 167:1413-1422.
37. Van Parijs L., Abbas A.K. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998, 280:243-248.
38. Wahl S.M., Wen J., Moutsopoulos N. TGF-beta: a mobile purveyor of immune privilege. Immunol. Rev. 2006, 213:213-227.
39. Yang P.L., Althage A., Chung J., Maier H., Wieland S., Isogawa M., Chisari F.V. Immune effectors required for hepatitis B virus clearance. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:798-802.
40. Yoshinaga-Hirabayashi T., Yoneda Y. Expression of SCC in ovarian granulosa cells and cultured cells, induced rapid structural changes in mitochondria. Ital. J. Anat. Embryol. 2001, 106:51-57.
41. Zhang C., Chakravarty D., Sakabe I., Mewani R.R., Boudreau H.E., Kumar D., Ahmad I., Kasid U.N. Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol. Ther. 2006, 13:947-955.
42. Zhang X., Wang J., Fan C., Li H., Sun H., Gong S., Chen Y.H., Shi Y. Crystal structure of TIPE2 provides insights into immune homeostasis. Nat. Struct. Mol. Biol. 2009, 16:89-90.
43. Zhang G., Hao C., Xi W., Lou Y., Wang X., Wang Y., Qu Z., Guo C., Chen Y.H., Zhang Y., Liu S.X. Tissue-specific expression of TIPE2 provides insights into its function. Mol. Immunol. 2010, 47:2435-2442.
44. Zhang S., Zhang Y., Wei X., Zhen J., Wang Z., Li M., Miao W., Ding H., Du P., Zhang W., He M., Yi F. Expression and regulation of a novel identified TNFAIP8 family is associated with diabetic nephropathy. Biochim. Biophys. Acta 2010, 1802:1078-1086.